WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
Canada - TSX:WELL - CA94947L1022 - Common Stock
4.44 CAD
-0.46 (-9.39%)
Taking everything into account, WELL scores 3 out of 10 in our fundamental rating. WELL was compared to 15 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of WELL have multiple concerns. WELL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year WELL has reported negative net income.
In the past year WELL had a positive cash flow from operations.
In multiple years WELL reported negative net income over the last 5 years.
WELL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of WELL (-6.37%) is worse than 60.00% of its industry peers.
Looking at the Return On Equity, with a value of -15.57%, WELL is in line with its industry, outperforming 46.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WELL has a Gross Margin of 39.21%. This is comparable to the rest of the industry: WELL outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of WELL has grown nicely.
The Profit Margin and Operating Margin are not available for WELL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WELL has more shares outstanding
Compared to 5 years ago, WELL has more shares outstanding
Compared to 1 year ago, WELL has an improved debt to assets ratio.
2.2 Solvency
WELL has an Altman-Z score of 1.04. This is a bad value and indicates that WELL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.04, WELL is in line with its industry, outperforming 53.33% of the companies in the same industry.
WELL has a Debt/Equity ratio of 0.68. This is a neutral value indicating WELL is somewhat dependend on debt financing.
WELL's Debt to Equity ratio of 0.68 is fine compared to the rest of the industry. WELL outperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.04 |
ROIC/WACCN/A
WACC8.52%
2.3 Liquidity
WELL has a Current Ratio of 0.93. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of WELL (0.93) is better than 73.33% of its industry peers.
WELL has a Quick Ratio of 0.93. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of WELL (0.92) is better than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The earnings per share for WELL have decreased strongly by -221.43% in the last year.
Looking at the last year, WELL shows a very strong growth in Revenue. The Revenue has grown by 20.36%.
WELL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.78% yearly.
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
3.2 Future
Based on estimates for the next years, WELL will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.87% on average per year.
Based on estimates for the next years, WELL will show a quite strong growth in Revenue. The Revenue will grow by 16.34% on average per year.
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y16.34%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for WELL. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 14.66, the valuation of WELL can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WELL indicates a rather cheap valuation: WELL is cheaper than 93.33% of the companies listed in the same industry.
WELL is valuated cheaply when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.66 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WELL is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 24.55 |
4.3 Compensation for Growth
WELL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WELL's earnings are expected to grow with 34.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.11%
EPS Next 3Y34.36%
5. Dividend
5.1 Amount
WELL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (11/7/2025, 7:00:00 PM)
4.44
-0.46 (-9.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners5.81%
Inst Owner ChangeN/A
Ins Owners22.59%
Ins Owner ChangeN/A
Market Cap1.13B
Revenue(TTM)1.10B
Net Income(TTM)-128.62M
Analysts81
Price Target7.82 (76.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-368.63%
Min EPS beat(2)-696.08%
Max EPS beat(2)-41.18%
EPS beat(4)0
Avg EPS beat(4)-1069.61%
Min EPS beat(4)-3335.29%
Max EPS beat(4)-41.18%
EPS beat(8)2
Avg EPS beat(8)1698.56%
EPS beat(12)3
Avg EPS beat(12)1044.26%
EPS beat(16)3
Avg EPS beat(16)671.21%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)1.59%
Revenue beat(4)1
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.94%
Revenue beat(12)6
Avg Revenue beat(12)-0.37%
Revenue beat(16)10
Avg Revenue beat(16)0.69%
PT rev (1m)0%
PT rev (3m)0.23%
EPS NQ rev (1m)30.36%
EPS NQ rev (3m)55.98%
EPS NY rev (1m)0%
EPS NY rev (3m)3.87%
Revenue NQ rev (1m)-0.68%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.66 | ||
| P/S | 1.03 | ||
| P/FCF | N/A | ||
| P/OCF | 243.26 | ||
| P/B | 1.36 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.55 |
EPS(TTM)-0.51
EYN/A
EPS(NY)0.3
Fwd EY6.82%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.41%
SpS4.32
BVpS3.25
TBVpS-2.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score2
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.34 | ||
| Cap/Depr | 25.5% | ||
| Cap/Sales | 1.94% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 6.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.04 |
F-Score2
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y16.34%
EBIT growth 1Y-144.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year286.51%
EBIT Next 3Y64.16%
EBIT Next 5Y42.51%
FCF growth 1Y-124.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.87%
OCF growth 3Y-22.85%
OCF growth 5YN/A
WELL HEALTH TECHNOLOGIES COR / WELL.CA FAQ
What is the ChartMill fundamental rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to WELL.CA.
What is the valuation status of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?
ChartMill assigns a valuation rating of 4 / 10 to WELL HEALTH TECHNOLOGIES COR (WELL.CA). This can be considered as Fairly Valued.
What is the profitability of WELL stock?
WELL HEALTH TECHNOLOGIES COR (WELL.CA) has a profitability rating of 2 / 10.
How financially healthy is WELL HEALTH TECHNOLOGIES COR?
The financial health rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) is 2 / 10.